David I. Quinn
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 0.2%
- Surgery top 0.5%
- Molecular Biology top 1%
- Cancer Research top 0.5%
- Co-authors
- Tanya B. DorffNicholas J. VogelzangDaniel P. PetrylakToni K. ChoueiriDean F. BajorinJoaquim BellmuntCora N. SternbergDavid J. Vaughn
- Topics
- Prostate Cancer Treatment and Research (156 papers)Bladder and Urothelial Cancer Treatments (94 papers)Cancer Immunotherapy and Biomarkers (86 papers)
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesNature Communications
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
David I. Quinn
405 papers receiving 13.9k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Oncology 5.8k
- Pulmonary and Respiratory Medicine 4.8k
- Surgery 4.5k
- Molecular Biology 4.0k
- Cancer Research 2.3k
Countries citing papers authored by David I. Quinn
This map shows the geographic impact of David I. Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David I. Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David I. Quinn more than expected).
Fields of papers citing papers by David I. Quinn
This network shows the impact of papers produced by David I. Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David I. Quinn. The network helps show where David I. Quinn may publish in the future.
Co-authorship network of co-authors of David I. Quinn
This figure shows the co-authorship network connecting the top 25 collaborators of David I. Quinn. A scholar is included among the top collaborators of David I. Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David I. Quinn. David I. Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 11 | |
| 5 | 10 | |
| 6 | 12 | |
| 7 | 30 | |
| 8 | 27 | |
| 9 | 8 | |
| 10 | 13 | |
| 11 | 0 | |
| 12 | 42 | |
| 13 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinomabreakdown → | 223 |
| 14 | 26 | |
| 15 | 76 | |
| 16 | 36 | |
| 17 | Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinomabreakdown → | 2374 |
| 18 | 37 | |
| 19 | 201 | |
| 20 | SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition. | 51 |
About David I. Quinn
David I. Quinn is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 420 papers that have together received 14.1k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (156 papers), Bladder and Urothelial Cancer Treatments (94 papers) and Cancer Immunotherapy and Biomarkers (86 papers). The work is most often cited by research in Oncology (5.8k citations), Cancer Research (2.3k citations) and Pulmonary and Respiratory Medicine (4.8k citations). David I. Quinn has collaborated with scholars based in United States, Australia and France. Frequent co-authors include Tanya B. Dorff, Nicholas J. Vogelzang, Daniel P. Petrylak, Toni K. Choueiri, Dean F. Bajorin, Joaquim Bellmunt, Cora N. Sternberg, David J. Vaughn, Andrea Necchi and Robert L. Sutherland. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.